相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of NF-κB by the CARD proteins
Changying Jiang et al.
IMMUNOLOGICAL REVIEWS (2012)
Regulation of NF-κB by ubiquitination and degradation of the IκBs
Naama Kanarek et al.
IMMUNOLOGICAL REVIEWS (2012)
NF-κB regulation: lessons from structures
Gourisankar Ghosh et al.
IMMUNOLOGICAL REVIEWS (2012)
It takes two to tango: IκBs, the multifunctional partners of NF-κB
Michael Hinz et al.
IMMUNOLOGICAL REVIEWS (2012)
Regulation of NF-κB by deubiquitinases
Edward W. Harhaj et al.
IMMUNOLOGICAL REVIEWS (2012)
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Yair Herishanu et al.
BLOOD (2011)
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome
Andrea Rinaldi et al.
BLOOD (2011)
CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
Brian J. Lannutti et al.
BLOOD (2011)
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E. M. Herman et al.
BLOOD (2011)
The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia
Julia Hoellenriegel et al.
BLOOD (2011)
Protein Kinase C Inhibitor Sotrastaurin Selectively Inhibits the Growth of CD79 Mutant Diffuse Large B-Cell Lymphomas
Tara L. Naylor et al.
CANCER RESEARCH (2011)
A20, ABIN-1/2, and CARD11 Mutations and Their Prognostic Value in Gastrointestinal Diffuse Large B-Cell Lymphoma
Gehong Dong et al.
CLINICAL CANCER RESEARCH (2011)
Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response
Baidong Hou et al.
IMMUNITY (2011)
Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma
Jia Ruan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
Analysis of the coding genome of diffuse large B-cell lymphoma
Laura Pasqualucci et al.
NATURE GENETICS (2011)
Critical role of PI3K signaling for NF-κB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells
Bernhard Kloo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell lines
Stephan Hailfinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cleavage of NIK by the API2-MALT1 Fusion Oncoprotein Leads to Noncanonical NF-κB Activation
Shaun Rosebeck et al.
SCIENCE (2011)
The Cytoskeleton Coordinates the Early Events of B-cell Activation
Naomi E. Harwood et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Mutations of CARD11 but not TNFAIP3 may activate the NF-κB pathway in primary CNS lymphoma
Manuel Montesinos-Rongen et al.
ACTA NEUROPATHOLOGICA (2010)
B Cell Signaling and Fate Decision
Tomohiro Kurosaki et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Early Events in B Cell Activation
Naomi E. Harwood et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Oncogenic CARD11 Mutations Induce Hyperactive Signaling by Disrupting Autoinhibition by the PKC-Responsive Inhibitory Domain
Rebecca L. Lamason et al.
BIOCHEMISTRY (2010)
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
Jonathan W. Friedberg et al.
BLOOD (2010)
PI3K/p110δ is a novel therapeutic target in multiple myeloma
Hiroshi Ikeda et al.
BLOOD (2010)
Classical and/or alternative NF-κB pathway activation in multiple myeloma
Yulia N. Demchenko et al.
BLOOD (2010)
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB-dependent lymphoma
Michael A. Milhollen et al.
BLOOD (2010)
Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
Sarah E. M. Herman et al.
BLOOD (2010)
Constitutive Canonical NF-κB Activation Cooperates with Disruption of BLIMP1 in the Pathogenesis of Activated B Cell-like Diffuse Large Cell Lymphoma
Dinis Pedro Calado et al.
CANCER CELL (2010)
BLIMP1 Is a Tumor Suppressor Gene Frequently Disrupted in Activated B Cell-like Diffuse Large B Cell Lymphoma
Jonathan Mandelbaum et al.
CANCER CELL (2010)
The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia
Lluis Espinosa et al.
CANCER CELL (2010)
Mutations in the genes coding for the NF-kappa B regulating factors I kappa B alpha and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma
Martin A. Schumacher et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1
John P. Graham et al.
IMMUNOLOGICAL REVIEWS (2010)
A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma
E. Chanudet et al.
LEUKEMIA (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling
Su-Chang Lin et al.
NATURE (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Lee A. Honigberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Targeting the dynamic HSP90 complex in cancer
Jane Trepel et al.
NATURE REVIEWS CANCER (2010)
A20: from ubiquitin editing to tumour suppression
Sarah G. Hymowitz et al.
NATURE REVIEWS CANCER (2010)
The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
Urban Novak et al.
BLOOD (2009)
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma
Kieron Dunleavy et al.
BLOOD (2009)
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
Keiichiro Honma et al.
BLOOD (2009)
Atacicept in relapsed/refractory multiple myeloma or active Waldenstrom's macroglobulinemia: a phase I study
J-F Rossi et al.
BRITISH JOURNAL OF CANCER (2009)
PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
Lakshmi Srinivasan et al.
CELL (2009)
IRAK-4 Inhibitors for Inflammation
Zhulun Wang et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas
Richard J. Bende et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
The Constant Region of the Membrane Immunoglobulin Mediates B Cell-Receptor Clustering and Signaling in Response to Membrane Antigens
Pavel Tolar et al.
IMMUNITY (2009)
The molecular assembly and organization of signaling active B-cell receptor oligomers
Pavel Tolar et al.
IMMUNOLOGICAL REVIEWS (2009)
Tyrosine kinases and their substrates in B lymphocytes
Tomohiro Kurosaki et al.
IMMUNOLOGICAL REVIEWS (2009)
Mutations of NFKBIA, encoding IκBα, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases
Annette Lake et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Roland Schmitz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells
Uta Ferch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Developmental Acquisition of the Lyn-CD22-SHP-1 Inhibitory Pathway Promotes B Cell Tolerance
Andrew J. Gross et al.
JOURNAL OF IMMUNOLOGY (2009)
Casein kinase 1α governs antigen-receptor-induced NF-κB activation and human lymphoma cell survival
Nicolas Bidere et al.
NATURE (2009)
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Mara Compagno et al.
NATURE (2009)
Frequent inactivation of A20 in B-cell lymphomas
Motohiro Kato et al.
NATURE (2009)
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Teresa A. Soucy et al.
NATURE (2009)
Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma
Stephan Hailfinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression
Heike Schmidlin et al.
BLOOD (2008)
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-κB pathways in subtypes of diffuse large B-cell lymphoma
Lloyd T. Lam et al.
BLOOD (2008)
TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma
Keiichiro Honma et al.
GENES CHROMOSOMES & CANCER (2008)
Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-κB pathway and promotes lymphomagenesis
Cornelia Hoemig-Hoelzel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Phospholipase C-γ2 and Vav cooperate within signaling microclusters to propagate B cell spreading in response to membrane-bound antigen
Michele Weber et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Homeostatic MyD88-dependent signals cause lethal inflammation in the absence of A20
Emre E. Turer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis
Verena Brune et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Molecular basis for the unique deubiquitinating activity of the NF-κB inhibitor A20
Su-Chang Lin et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-κB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association
Ryan R. McCully et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
IRF4 addiction in multiple myeloma
Arthur L. Shaffer et al.
NATURE (2008)
Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling
Sivakumar Vallabhapurapu et al.
NATURE IMMUNOLOGY (2008)
Noncanonical NF-kappa B activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK
Brian J. Zarnegar et al.
NATURE IMMUNOLOGY (2008)
T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-κB inhibitor A20
Beatrice Coornaert et al.
NATURE IMMUNOLOGY (2008)
The proteolytic activity of the paracaspase MALT1 is key in T cell activation
Fabien Rebeaud et al.
NATURE IMMUNOLOGY (2008)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Compensatory IKKα activation of classical NF-κB signaling during IKKβ inhibition identified by an RNA interference sensitization screen
Lloyd T. Lam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
Georg Lenz et al.
SCIENCE (2008)
Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex
Atsushi Matsuzawa et al.
SCIENCE (2008)
CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand
David Depoil et al.
NATURE IMMUNOLOGY (2008)
IκB kinase β-induced phosphorylation of CARMA1 contributes to CARMA1-Bcl10-MALT1 complex formation in B cells
Hisaaki Shinohara et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival
Christoph Mancao et al.
BLOOD (2007)
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma
J. Iqbal et al.
LEUKEMIA (2007)
Selective predisposition to bacterial infections in IRAK-4-deficient children:: IRAK-4-dependent TLRs are otherwise redundant in protective immunity
Cheng-Lung Ku et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
NF-κB is a negative regulator of IL-1β secretion as revealed by genetic and pharmacological inhibition of IKKβ
Florian R. Greten et al.
CELL (2007)
A dual role for the API2 moiety in API2-MALT1-dependent NF-κB activation:: heterotypic oligomerization and TRAF2 recruitment
P. C. Lucas et al.
ONCOGENE (2007)
Genome-wide array-based comparative genomic hybridization of ocular marginal zone B cell lymphoma: Comparison with pulmonary and nodal marginal zone B cell lymphoma
Won Seog Kim et al.
GENES CHROMOSOMES & CANCER (2007)
Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma
Jonathan J. Keats et al.
CANCER CELL (2007)
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma
Christina M. Annunziata et al.
CANCER CELL (2007)
Targeting NF-κB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth
Michel Jourdan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
CARMA1 coiled-coil domain is involved in the oligomerization and subcellular localization of CARMA1 and is required for T cell receptor-induced NF-κB activation
Matthew J. Tanner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-κB activation by API2•MALT1 fusions
Heidi Noels et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Gains of REL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein
Marc A. Weniger et al.
GENES CHROMOSOMES & CANCER (2007)
Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL
April Chiu et al.
BLOOD (2007)
Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NF kappa B
Jinbo Yang et al.
GENES & DEVELOPMENT (2007)
Targeting the NF-kappa B signaling pathway in Notch1-induced T-cell leukemia
Tomas Vilimas et al.
NATURE MEDICINE (2007)
Immunologically active autoantigens: The role of Toll-like receptors in the development of chronic inflammatory disease
Ann Marshak-Rothstein et al.
ANNUAL REVIEW OF IMMUNOLOGY (2007)
The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes
David J. Rawlings et al.
NATURE REVIEWS IMMUNOLOGY (2006)
MLN120B, a novel IκB kinase β inhibitor, blocks multiple myeloma cell growth in vitro and in vivo
Teru Hideshima et al.
CLINICAL CANCER RESEARCH (2006)
Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis
Zhengfan Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Igβ tyrosine residues contribute to the control of B cell receptor signaling by regulating receptor internalization
Anna Gazumyan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination
Ulf Klein et al.
NATURE IMMUNOLOGY (2006)
Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-κB signaling
Ramin Massoumi et al.
CELL (2006)
Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas
W Tam et al.
BLOOD (2006)
Selective expansion of marginal zone B cells in Eμ-API2-MALT1 mice is linked to enhanced IκB kinase γ polyubiquitination
Mathijs Baens et al.
CANCER RESEARCH (2006)
B cell ligand discrimination through a spreading and contraction response
SJ Fleire et al.
SCIENCE (2006)
A loss-of-function RNA interference screen for molecular targets in cancer
VN Ngo et al.
NATURE (2006)
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma
L Pasqualucci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas
SM Hu et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A uniform activated B-cell-like in-immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases
S Camilleri-Broet et al.
BLOOD (2006)
Phosphorylation of the CARMA1 linker controls NF-κB activation
K Sommer et al.
IMMUNITY (2005)
Phosphorylation of CARMA1 plays a critical role in T cell receptor-mediated NF-κB activation
R Matsumoto et al.
IMMUNITY (2005)
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature
J Moreaux et al.
BLOOD (2005)
Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity
RJ Bende et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas
AJM Ferreri et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
B cell receptor signal strength determines B cell fate
S Casola et al.
NATURE IMMUNOLOGY (2004)
Immunoproliferative small intestinal disease associated with Campylobacter jejuni
M Lecuit et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
BCMA is essential for the survival of long-lived bone marrow plasma cells
BP O'Connor et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
IE Wertz et al.
NATURE (2004)
Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation
M Broemer et al.
ONCOGENE (2004)
Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation
GX Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer
M Kraus et al.
CELL (2004)
Src-family kinases in B-cell development and signaling
SB Gauld et al.
ONCOGENE (2004)
The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes
LJ Sun et al.
MOLECULAR CELL (2004)
Receptor-specific signaling for both the alternative and the canonical NF-κB activation pathways by NF-κB-inducing kinase
P Ramakrishnan et al.
IMMUNITY (2004)
CARMA1, BCL-10 and MALT1 in lymphocyte development and activation
M Thome
NATURE REVIEWS IMMUNOLOGY (2004)
The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor κB activation by tumor necrosis factor
A Regamey et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Regulation of NF-κB-dependent lymphocyte activation and development by paracaspase
AA Ruefli-Brasse et al.
SCIENCE (2003)
Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells
F Emmerich et al.
JOURNAL OF PATHOLOGY (2003)
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
A Rosenwald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Predominant autoantibody production by early human B cell precursors
H Wardemann et al.
SCIENCE (2003)
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma
G Wright et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
TR Brummelkamp et al.
NATURE (2003)
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
A Kovalenko et al.
NATURE (2003)
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
E Trompouki et al.
NATURE (2003)
Mice lacking the CARD of CARMA1 exhibit defective B lymphocyte development and impaired proliferation of their B and T lymphocytes
K Newton et al.
CURRENT BIOLOGY (2003)
Requirement for CARMA1 in antigen receptor-induced NF-κB activation and lymphocyte proliferation
T Egawa et al.
CURRENT BIOLOGY (2003)
MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma
D Sanchez-Izquierdo et al.
BLOOD (2003)
Identifying the MAGUK protein CARMA-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis
JE Jun et al.
IMMUNITY (2003)
The MAGUK family protein CARD11 is essential for lymphocyte activation
H Hara et al.
IMMUNITY (2003)
Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma
TFE Barth et al.
BLOOD (2003)
The tumor microenvironment: focus on myeloma
WS Dalton
CANCER TREATMENT REVIEWS (2003)
Pyogenic bacterial infections in humans with IRAK-4 deficiency
C Picard et al.
SCIENCE (2003)
Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas
EMM Penas et al.
LEUKEMIA (2003)
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
KJ Savage et al.
BLOOD (2003)
Differential requirement for Malt1 in T and B cell antigen receptor signaling
J Ruland et al.
IMMUNITY (2003)
Molecular mechanisms of novel therapeutic approaches for multiple myeloma
T Hideshima et al.
NATURE REVIEWS CANCER (2002)
CD40 regulates the processing of NF-κB2 p100 to p52
HJ Coope et al.
EMBO JOURNAL (2002)
CARD11 mediates factor-specific activation of NF-κB by the T cell receptor complex
JL Pomerantz et al.
EMBO JOURNAL (2002)
BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells
E Claudio et al.
NATURE IMMUNOLOGY (2002)
A requirement for CARMA1 in TCR-induced NF-κB activation
DH Wang et al.
NATURE IMMUNOLOGY (2002)
CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-κB activation
O Gaide et al.
NATURE IMMUNOLOGY (2002)
Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection
O Hermine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Post-transplantation lymphoproliferative disease in Chinese: The Queen Mary Hospital experience in Hong Kong
WY Au et al.
LEUKEMIA & LYMPHOMA (2002)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
NF-κB as a therapeutic target in multiple myeloma
T Hideshima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2
S Joos et al.
BLOOD (2002)
Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma
JI Martín-Subero et al.
BLOOD (2002)
Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
RE Davis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
A Rosenwald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Functional expression of receptor activator of nuclear factor κB in Hodgkin disease cell lines
P Fiumara et al.
BLOOD (2001)
Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway
U Senftleben et al.
SCIENCE (2001)
Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-κB induction
LM McAllister-Lucas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF-κB signaling pathway
PC Lucas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-κB activation
O Gaide et al.
FEBS LETTERS (2001)
CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-κB
J Bertin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Defective lymphotoxin-β receptor-induced NF-κB transcriptional activity in NIK-deficient mice
L Yin et al.
SCIENCE (2001)
Coiled coils: a highly versatile protein folding motif
P Burkhard et al.
TRENDS IN CELL BIOLOGY (2001)
NF-κB-inducing kinase regulates the processing of NF-κB2 p100
GT Xiao et al.
MOLECULAR CELL (2001)
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
AS Baldwin
JOURNAL OF CLINICAL INVESTIGATION (2001)
Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice
EG Lee et al.
SCIENCE (2000)
BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control
AL Shaffer et al.
IMMUNITY (2000)
Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI
SA Marsters et al.
CURRENT BIOLOGY (2000)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin
E Roggero et al.
HUMAN PATHOLOGY (2000)
Clonal deleterious mutations in the IκBα gene in the malignant cells in Hodgkin's lymphoma
B Jungnickel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
